Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 5—May 2014
Research

Persistence and Complex Evolution of Fluoroquinolone-Resistant Streptococcus pneumoniae Clone

Debby Ben-DavidComments to Author , Mitchell J. Schwaber, Amos Adler, Samira Masarwa, Rotem Edgar, Shiri Navon-Venezia, David Schwartz, Nurith Porat, Tali Kotlovsky, Nikolay Polivkin, Irina Weinberg, Avraham Lazary, Nissim Ohana, and Ron Dagan
Author affiliations: National Center for Infection Control, Tel Aviv, Israel (D. Ben-David, M.J. Schwaber, A. Adler, S. Masarwa, R. Edgar, S. Navon-Venezia); Sourasky Medical Center, Tel Aviv (D. Schwartz, N. Porat, T. Kotlovsky, R. Dagan); Ben-Gurion University of the Negev, Beer-Sheva (N. Porat, R. Dagan); Reuth Medical Center, Tel Aviv (N. Polivkin, I. Weinberg, A. Lazary, N. Ohana)

Main Article

Figure 1

Serotyping and clonal analysis of the first point-prevalence survey of Streptococcus pneumoniae infection in a post–acute care facility, Israel, 2006–2011. FQ fluoroquinolone; FQISP, fluoroquinolone-intermediate S. pneumoniae; FQRSP fluoroquinolone-resistant S. pneumoniae.

Figure 1. Serotyping and clonal analysis of the first point-prevalence survey of Streptococcus pneumoniae infection in a post–acute care facility, Israel, 2006–2011FQ fluoroquinolone; ST, sequence type; FQISP, fluoroquinolone-intermediate Spneumoniae; FQRSP fluoroquinolone-resistant Spneumoniae.

Main Article

Page created: April 16, 2014
Page updated: April 16, 2014
Page reviewed: April 16, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external